Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · January 22, 2022

30-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement

JACC: Cardiovascular Interventions

 

Additional Info

Disclosure statements are available on the authors' profiles:

JACC: Cardiovascular Interventions
30-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results
JACC Cardiovasc Interv 2022 Jan 10;15(1)80-89, F Zahr, HK Song, SM Chadderdon, H Gada, M Mumtaz, T Byrne, M Kirshner, T Bajwa, E Weiss, S Kodali, I George, J Heiser, WM Merhi, JJ Thaden, A Zhang, DS Lim, MJ Reardon, DH Adams, MJ Mack, MB Leon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading